941 related articles for article (PubMed ID: 9845381)
1. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
[TBL] [Abstract][Full Text] [Related]
2. Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor.
Patchen ML; Liang J; Vaudrain T; Martin T; Melican D; Zhong S; Stewart M; Quesenberry PJ
Stem Cells; 1998; 16(3):208-17. PubMed ID: 9617896
[TBL] [Abstract][Full Text] [Related]
3. Hemopoietic effects of intravenous soluble glucan administration.
Patchen ML; MacVittie TJ
J Immunopharmacol; 1986; 8(3):407-25. PubMed ID: 3760593
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
[TBL] [Abstract][Full Text] [Related]
5. Mobilization of hematopoietic progenitor cells by yeast-derived beta-glucan requires activation of matrix metalloproteinase-9.
Cramer DE; Wagner S; Li B; Liu J; Hansen R; Reca R; Wu W; Surma EZ; Laber DA; Ratajczak MZ; Yan J
Stem Cells; 2008 May; 26(5):1231-40. PubMed ID: 18339771
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression.
Kovacs CJ; Kerr JA; Daly BM; Evans MJ; Johnke RM
Anticancer Res; 1998; 18(3A):1805-12. PubMed ID: 9673408
[TBL] [Abstract][Full Text] [Related]
7. Survival enhancement and hemopoietic regeneration following radiation exposure: therapeutic approach using glucan and granulocyte colony-stimulating factor.
Patchen ML; MacVittie TJ; Solberg BD; Souza LM
Exp Hematol; 1990 Oct; 18(9):1042-8. PubMed ID: 1697806
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro interaction between interleukin 6 and granulocyte colony-stimulating factor in the regulation of murine hematopoiesis.
Pojda Z; Tanaka K; Aoki Y; Tsuboi A
Exp Hematol; 1992 Aug; 20(7):874-8. PubMed ID: 1378408
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.
van Os R; Robinson S; Sheridan T; Mauch PM
Stem Cells; 2000; 18(2):120-7. PubMed ID: 10742384
[TBL] [Abstract][Full Text] [Related]
10. The in vitro and in vivo effects of stem cell factor on human hematopoiesis.
Hoffman R; Tong J; Brandt J; Traycoff C; Bruno E; McGuire BW; Gordon MS; McNiece I; Srour EF
Stem Cells; 1993 Jul; 11 Suppl 2():76-82. PubMed ID: 7691331
[TBL] [Abstract][Full Text] [Related]
11. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
Drize N; Chertkov J; Samoilina N; Zander A
Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
[TBL] [Abstract][Full Text] [Related]
12. Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factor.
Hestdal K; Jacobsen SE; Ruscetti FW; Longo DL; Boone TC; Keller JR
Exp Hematol; 1993 Jun; 21(6):799-805. PubMed ID: 8500577
[TBL] [Abstract][Full Text] [Related]
13. Synergy between recombinant human IL-1 alpha (rHuIL-1) and M-CSF (rHuM-CSF) during the recovery of murine hematopoietic activity in myelosuppressed animals: abbreviated versus chronic administration of rHuM-CSF.
Kovacs CJ; Harrell JP; Gooya JM; Evans MJ; Johnke RM
Exp Hematol; 1992 Jun; 20(5):582-9. PubMed ID: 1587305
[TBL] [Abstract][Full Text] [Related]
14. Hematologic effects of stem cell factor alone and in combination with G-CSF and GM-CSF in vivo and in vitro in rodents.
Ulich TR; Yi ES; Yin S; del Castillo J; McNiece I; Yung YP; Zsebo KM
Int Rev Exp Pathol; 1993; 34 Pt A():215-33. PubMed ID: 7681048
[TBL] [Abstract][Full Text] [Related]
15. Stem cell responses in myelosuppressed mice following sequential treatment with recombinant human interleukin 1 (rHuIL-1), recombinant murine interleukin 3 (rMuIL-3) and recombinant human macrophage colony-stimulating factor (rHuM-CSF).
Kovacs CJ; Harrell JP; Evans MJ; Abernathy RS; Roberts CJ; Johnke RM
Stem Cells; 1994 Jan; 12(1):103-13. PubMed ID: 8142915
[TBL] [Abstract][Full Text] [Related]
16. Combinations of colony-stimulating factors promote enhanced proliferative potential in enriched granulocyte-macrophage colony-forming cells.
Heyworth CM; Dexter TM; Nicholls SE; Whetton AD
Exp Hematol; 1994 Oct; 22(11):1089-94. PubMed ID: 7925776
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effect of orally administered soluble beta-(1-3),(1-6)-D-glucan and of G-CSF on the recovery of murine hematopoiesis.
Harnack U; Eckert K; Fichtner I; Pecher G
In Vivo; 2010; 24(1):59-63. PubMed ID: 20133977
[TBL] [Abstract][Full Text] [Related]
18. The polysaccharide, PGG-glucan, enhances human myelopoiesis by direct action independent of and additive to early-acting cytokines.
Turnbull JL; Patchen ML; Scadden DT
Acta Haematol; 1999; 102(2):66-71. PubMed ID: 10529508
[TBL] [Abstract][Full Text] [Related]
19. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
[TBL] [Abstract][Full Text] [Related]
20. Effects of in vivo administration of adamantylamide dipeptide on bone marrow granulocyte-macrophage hemopoietic progenitor cells (GM-CFC) and on ability of serum of the treated mice to stimulate GM-CFC colony formation in vitro: comparison with muramyl dipeptide and glucan.
Vacek A; Hofer M; Masek K
Immunopharmacol Immunotoxicol; 1999 Feb; 21(1):1-14. PubMed ID: 10084327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
